In this issue:
Healthcare resource utilisation in GPP
Guselkumab for moderate-to-severe paediatric plaque psoriasis
Safety assessment of apremilast
Antibiotic therapy in psoriasis patients with active streptococcal infection
Long-term real-world effectiveness of deucravacitinib in psoriasis
Real-world 52-week effectiveness of deucravacitinib in psoriasis
QoL in generalised pustular psoriasis
Oral roflumilast for psoriasis
Real-world results of secukinumab for paediatric GPP
Management of female paediatric vulvar psoriasis
Please login below to download this issue (PDF)